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Abstract 
Background: Cowden syndrome is an autosomal dominant disorder with a predisposition to multiple benign and 
malignant tumors. In our patient, in addition to breast and endometrial malignancies as well as facial trichilemmo‑
mas, she was noted to have multiple meningiomas, pancreatic lipomas and lung cysts. These latter lesions have been 
noted in previous Cowden syndrome case reports, but are not included in the diagnostic criteria at this time. To our 
knowledge, this is the first case of multiple meningiomas in this syndrome. Further studies are therefore warranted to 
assess the significance of these findings in Cowden syndrome.
Case presentation: A middle‑aged Afro‑Caribbean known endometrial carcinoma patient (post surgery and adju‑
vant radiotherapy), presented with a locally advanced breast carcinoma. She received neoadjuvant chemotherapy 
followed by a modified radical mastectomy and axillary lymph node clearance. Her past medical history included a 
sphenoid wing meningioma for which she received definitive external beam radiotherapy. She was also known to 
have a multinodular goiter, anal polyp and longstanding mucocutaneous lesions. Further workup revealed additional 
smaller meningiomas, a parotid arteriovenous malformation, a lung cyst and pancreatic lipomas. Overall, consortium 
criteria were met for the diagnosis of Cowden syndrome. Furthermore, genetic testing identified a pathogenic muta‑
tion in the PTEN gene. She will be closely followed with annual clinical examination, dermatologic assessment and 
screening colonoscopies. She will perform interval whole body contrast enhanced CT for continued surveillance for 
metastatic disease.
Conclusion: Cowden syndrome is likely to be an under diagnosed condition, but critically important to identify due 
to its cancer predisposition. When encountering multi‑organ tumors, diagnostic criteria for Cowden syndrome should 
be sought in order to increase the diagnostic rates. Cancer surveillance for carcinoma detection in the early and cura‑
tive stages remains the most critical aspect of management.
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Background
Although rare, cowden syndrome (CS) or phosphate 
and tensin homolog (PTEN) hamartoma syndrome is an 
autosomal dominant disorder characterized by multi-
ple hamartomas throughout the body with an increased 
lifetime risk of several carcinomas [1, 2]. These include 
breast, thyroid, endometrial, colorectal and renal carci-
nomas [2, 3]. Surveillance for early cancer detection is 
therefore essential to ensure optimal survival for patients 
afflicted with this syndrome. Due to its varied presenta-
tion however, this condition can be difficult to recognize 
and is often under diagnosed; although mucocutaneous 
features are present in 99 % of patients by the third dec-
ade of life [4]. Clinicians must therefore also be aware of 
the other manifestations of CS including macrocephaly, 
arteriovenous malformations, gastrointestinal polyps, 
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testicular lipomatosis and thyroid nodules, in order to 
increase the diagnostic rates for this disorder [1, 2]. There 
is currently insufficient data to include meningiomas 
in the diagnostic criteria of CS due to its prevalence in 
the general population [2]. Meningiomas however have 
been described in a number of previous case reports 
[5] and the multiplicity of these lesions is of note in this 
patient. A thin walled lung cyst and pancreatic lipomas 
were additional findings in this patient’s imaging studies. 
These have been noted in previous case reports [6, 7] and 
possibly represent hamartomatous lesions. Further study 
is therefore warranted to ascertain the relevance of these 
findings to CS.
Case presentation
A 57-year old Afro-Caribbean female presented with 
a T4N2M0 triple negative mucinous right breast car-
cinoma. She was 1-year post radical hysterectomy and 
adjuvant radiation for abnormal uterine bleeding, with 
the corresponding histology of endometrial carcinoma as 
well as multiple uterine leiomyomas. She had a 12-year 
history of left exophthalmos secondary to a sphenoid 
wing meningioma, for which she received external beam 
radiotherapy. She also had a history of rectal bleed-
ing secondary to an anal polyp, which was resected and 
proved to be a tubular adenoma.
Several dermatological lesions were noted on exami-
nation, which the patient reported to be present ‘since 
childhood’. These included flesh colored papules in the 
perinasal region, warty papules on the tongue, hands and 
feet as well as palmar pits. A visible right neck swelling 
was also noted and further questioning revealed symp-
toms of dysphagia as well as a history of prior left thy-
roidectomy for a multinodular goiter. She did not report 
any shortness of breath, palpitations or significant weight 
loss. A left cheek swelling was palpated, which was pul-
satile in nature. Our patient also had a thoracolumbar 
scoliosis and complained of symptoms of sciatica. Unfor-
tunately, as she was estranged from her family, her fam-
ily medical history and genetic testing of family members 
could not be obtained.
Hematological and biochemical investigations as well 
as thyroid function tests were all within normal limits. 
Contrast enhanced CT of the brain, neck, chest, abdo-
men and pelvis was performed for staging purposes and 
to monitor known lesions. CT revealed a left sphenoid 
wing meningioma with extra-conal extension and result-
ant left optic nerve impingement and proptosis. Two 
other homogenously enhancing extra-axial lesions were 
noted, with one showing calcification, consistent with 
the presence of additional smaller meningiomas. These 
were stable on imaging for 5 years (Fig. 1). The pulsatile 
left cheek swelling corresponded with a left parotid arte-
riovenous malformation, with the arterial feeder arising 
from the left external carotid artery (Fig.  2). A left thy-
roidectomy was noted with multinodular enlargement of 
the right thyroid lobe and isthmus along with retroster-
nal extension and marked tracheal deviation to the left 
(Fig.  3). The right breast lesion was partially imaged on 
CT preoperatively, along with level I and II axillary ade-
nopathy (Fig. 4). Of note was a thin walled lung cyst in 
the periphery of the left upper lobe (Fig. 5).
Multiple hypo enhancing splenic lesions were seen, 
likely representing hamartomas, as well as several sub-
centimeter fat density lesions within the pancreas (Fig. 6). 
The pelvis showed post surgical changes with no evi-
dence of local recurrence or lymphadenopathy. No 
metastatic disease was evident. Mammogram of the left 
breast showed no evidence of spiculated masses, clus-
tered micro calcifications or architectural distortion. Our 
patient declined biopsy of her skin lesions however these 
were assessed by dermatologists and clinically confirmed 
to be facial trichilemmomas, acral keratosis, palmar pits 
and oral papillomas. MRI of the spine revealed a thora-
columbar scoliosis with spondylosis and multilevel disc 
disease however there was no evidence of metastatic 
disease, dural ectasia or extra medullary lesions. Genetic 
testing identified a pathogenic mutation in the PTEN 
gene: c.697C > T (pArg233*).
Following neoadjuvant chemotherapy, our patient 
underwent a right modified radical mastectomy with 
axillary lymph node dissection. Although she declined 
debulking operative intervention for the sphenoid wing 
meningioma, she was treated with external beam radio-
therapy; with stability of this lesion noted post radiation. 
Prophylactic mastectomy for the contralateral breast 
was discussed at the multidisciplinary team meeting, 
however our patient opted to instead have regular clini-
cal and imaging examinations for screening of the left 
breast.
There has been no clinical or radiological evidence of 
local or nodal recurrence of her endometrial carcinoma. 
FNAC of the right thyroid showed no evidence of malig-
nancy, however the patient is considering thyroidectomy 
due to worsening symptoms of dysphagia. She continues 
to be monitored in the outpatient clinic setting for her 
sphenoid wing meningioma and parotid AVM, however 
she is not keen on operative management. For follow up, 
she will be offered annual thorough clinical examination 
including dermatologic assessment as well as screening 
colonoscopies. She will also perform interval whole body 
contrast enhanced CT for continued surveillance for 
metastatic disease. On this examination, her kidneys will 
also be closely monitored for renal cell carcinoma.
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Discussion
Cowden syndrome (CS) is an autosomal dominant dis-
order that is associated with the formation of hamar-
tomatous tumors as well as a predisposition to a 
number of malignancies; mainly breast, thyroid and 
endometrial carcinomas [1, 2]. CS is estimated to occur 
in 1:200,000 patients however this is likely to be an 
underestimate due to current underdiagnosis [4]. CS 
is the prototype of the PTEN hamartoma tumor syn-
drome disorders and is linked to germline mutations 
in the phosphate and tensin homolog (PTEN) tumor 
suppressor gene [1, 2]. Molecular genetic testing can 
be performed to assess for this mutation however new 
prospective research identified these mutations in only 
25  % of involved individuals [8]. The consensus diag-
nostic criteria should therefore be used as the mainstay 
of diagnosis at this time. This has recently been revised 
by Pilarski et al. [2] (Table 1).
Women with CS were considered to have a lifetime risk 
of 25–50 % for developing breast cancer and 5–10 % for 
developing endometrial cancer, however more recent 
reports suggest an even greater risk of up to 85  % for 
breast cancer and 28  % for endometrial cancer [1–3]. 
Breast cancers may also develop in CS at an earlier age 
compared with the general population [2]. Anecdotally, 
benign breast and uterine disease such as fibroadenomas 
and leiomyomas have frequently been reported as clinical 
features of CS, however as these are common conditions 
in the healthy adult population, it is unclear whether the 
rate in CS is significantly increased [2].
Current data supports the hypothesis that both benign 
and malignant thyroid disease are a part of CS how-
ever again, due to the prevalence in the general popula-
tion, this has a low predictive value for identifying those 
affected by mutations [2]. In particular however, folli-
cular thyroid cancer appears overrepresented in PTEN 
Fig. 1 Axial contrast enhanced CT of the brain. a Large homogenously enhancing left sphenoid wing meningioma with associated hyperostosis 
and extension into the left anterior temporal fossa and left extraconal space. b Smaller well‑defined enhancing extra‑axial lesion in the right frontal 
lobe (arrow), consistent with a convexity meningioma
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mutation carriers compared with the general population 
[2]. Follicular thyroid cancer is thus included as a major 
criterion with papillary thyroid cancer and benign thy-
roid nodules considered as minor criteria [2] (Table  1). 
Other neoplasms including colorectal cancers, skin can-
cers and renal cell cancers are suspected to be associated 
with CS; with one study estimating the lifetime risk of 
colorectal cancer at 9 % and renal cell carcinoma at 34 % 
[2, 3].
Findings of an adult onset dysplastic gangliocytoma of 
the cerebellum or Lhermitte-Duclos disease (a benign, 
slow growing hamartoma) as well as macrocephaly are 
included as major criteria for the diagnosis of PTEN 
hamartoma tumor syndrome [2] (Table  1). Although a 
number of cases of meningioma have been reported in 
CS in the literature [5], there is insufficient data currently 
Fig. 2 Axial contrast enhanced CT at the level of C1. Left parotid 
arteriovenous malformation with a left external carotid artery branch 
feeding vessel (straight arrow), along with an enlarged draining vein 
(curved arrow)
Fig. 3 Axial contrast enhanced CT at the level of the thyroid gland. 
Left thyroidectomy noted with multinodular enlargement of the right 
thyroid lobe with marked tracheal deviation to the left
Fig. 4 Axial contrast enhanced CT of the Chest. The right breast 
lesion was partially imaged (curved arrow) pre‑operatively along with 
skin thickening and level I and II axillary adenopathy (straight arrow)
Fig. 5 Axial CT of the Chest: Pulmonary window. A solitary thin 
walled lung cyst was present in the periphery of the left upper lobe 
(arrow)
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to confirm this association [2]. Multiple meningiomas 
were however noted in our patient on imaging. CT in our 
patient also demonstrated multiple lipomas in the pan-
creas as well as a thin walled cyst in the lung. These find-
ings were noted radiologically in previous case reports [6, 
7] with histological confirmation of a mesenchymal cystic 
hamartoma of the lung by Cottin et al. [7]. Future studies 
are therefore warranted to determine the significance of 
these imaging findings in the diagnosis of CS.
Trichilemmomas are lichenoid, skin-colored papules 
with a smooth surface. They are rarely sporadic and usu-
ally multiple at presentation of CS, in the central portion 
of the face [9]. The presence of at least 3 is thus included 
as a major criterion [2] (Table  1). They can however be 
mistaken for a common facial wart hence histopathol-
ogy may be necessary. Other dermatological lesions 
include oral papillomas, mucocutaneous neuromas, acral 
Fig. 6 Axial contrast enhanced CT of the Abdomen. Multiple hypo 
enhancing splenic lesions were seen (curved arrow), likely represent‑
ing hamartomas as well as subcentimeter fat density lesions within 
the pancreas (average HU = −70) (straight arrows)





Gastrointestinal hamartomas (including ganglioneuromas, but excluding hyperplastic polyps; ≥3)
Lhermitte‑Duclos disease (adult)
Macrocephaly (≥97 percentile: 58 cm for females, 60 cm for males)
Macular pigmentation of the glans penis
Multiple mucocutaneous lesions (any of the following):
Multiple trichilemmomas (≥3, at least one biopsy proven)
Acral keratoses (≥3 palmoplantar keratotic pits and/or acral hyperkeratotic papules)
Mucocutaneous neuromas (≥3)




Esophageal glycogenic acanthosis (≥3)
Lipomas (≥3)
Mental retardation (i.e., IQ ≤ 75)
Renal cell carcinoma
Testicular lipomatosis
Thyroid cancer (papillary or follicular variant of papillary)
Thyroid structural lesions (e.g., adenoma, multinodular goiter)
Vascular anomalies (including multiple intracranial developmental venous anomalies)
Operational diagnosis in an individual (either of the following)
1. Three or more major criteria, but one must include macrocephaly, Lhermitte‑Duclos disease, or gastrointestinal hamartomas; or
2. Two major and three minor criteria
Operational diagnosis in a family where one individual meets revised PTEN hamartoma tumor syndrome clinical diagnostic criteria or has a PTEN mutation
1. Any two major criteria with or without minor criteria; or
2. One major and two minor criteria; or
3. Three minor criteria
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keratosis and penile pigmentation [2]. As 99 % of individ-
uals manifest with mucocutaneous stigmata by the 3rd 
decade of life, it is an extremely important heralding sign 
of the disease [4].
Most critical in the management of CS is surveillance 
for early cancer detection, resulting in improved over-
all survival. All CS patients should undergo an annual 
thyroid ultrasound scan and dermatologic evaluation. 
Women should receive an annual mammogram and 
breast MRI from age 30 along with annual transvaginal 
ultrasound and blind suction endometrial biopsies [1, 3]. 
Prophylactic mastectomy or prophylactic hysterectomy 
may also be considered after appropriate counseling. All 
adults with CS should have a colonoscopy beginning at 
age 35 as well as renal imaging every 2 years, beginning 
at age 40. These screening measures may also be under-
taken 5–10  years before any known family history of a 
particular type of carcinoma (whichever is earlier) [10].
Interestingly, a number of familial syndromes have 
been linked by the shared loss of function of tumor regu-
lator genes, leading to increased activity of the mamma-
lian target of rapamycin (mTOR) pathway [11]. These 
syndromes include Neurofibromatosis type 1, tuberous 
sclerosis complex, Birt-Hogg-Dube, Peutz-Jeghers syn-
drome and Cowden syndrome [12]. This has led to clini-
cal trials for mTOR inhibitors as a chemo preventative 
and therapeutic modality for these conditions [13, 14].
Conclusion
Cowden syndrome is likely to be an underdiagnosed 
entity due to its diverse phenotypic features. When 
encountering multi-organ pathologies such as macro-
cephaly, arteriovenous malformations and benign breast 
and thyroid disease, CS should be considered with a 
search for other manifestations, particularly the charac-
teristic trichilemmomas. Future studies are warranted 
to ascertain any significant links between meningiomas, 
pancreatic lipomas and lung cysts in the diagnostic cri-
teria for CS. Although Cowden syndrome predisposes to 
a number of malignancies, screening measures can lead 
to early detection and improved survival and is therefore 
the hallmark of disease management at this time.
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